Dr. Thomas Trilling is a seasoned pharmaceutical executive with extensive experience in oncology, rare diseases, and biopharmaceuticals. Currently serving as the Country Manager for Oncology at Regeneron since May 2023, Dr. Trilling's previous roles include positions such as Vice President and Commercial Head of Europe at Nektar Therapeutics and General Manager for D-A-CH at Servier. With a proven track record in building and managing commercial infrastructures, launching innovative products, and developing strategic partnerships, Dr. Trilling has achieved notable recognition in the industry, including leading Basilea Pharmaceutica to be awarded as the best company in its specialty. Dr. Trilling holds a Medical Doctor degree from the University of Münster, obtained between 1990 and 1996.
This person is not in the org chart
This person is not in any teams
This person is not in any offices